 | • レポートコード：MRC2312MG08338 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のジェネリック医薬品適合性評価サービス市場規模と予測を収録しています。・世界のジェネリック医薬品適合性評価サービス市場：売上、2018年-2023年、2024年-2029年 ・世界のジェネリック医薬品適合性評価サービス市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のジェネリック医薬品適合性評価サービス市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「オンラインサービス」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ジェネリック医薬品適合性評価サービスのグローバル主要企業は、PHDS Healthcare Research、 YUANBO、 HiCrystal、 Agilent、 Waters、 Thermo Fisher Scientific、 BOC Sciences、 JOINN、 SHIMADZU、 Tigermed、 MEDICILON、 FUKANGREN、 Shenzhen Real-chemstandards Bio-Tech.,Co.,Ltd、 Xiamen Bioendo Technology Co.,Ltd、 ChoiPharm、 WuXi AppTec、 Puhui Pharma、 Beijing Honghui Meditech Co., Ltd.、 NKD PHARM CO, LTDなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、ジェネリック医薬品適合性評価サービスのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のジェネリック医薬品適合性評価サービス市場：タイプ別、2018年-2023年、2024年-2029年 世界のジェネリック医薬品適合性評価サービス市場：タイプ別市場シェア、2022年 ・オンラインサービス、オフラインサービス 世界のジェネリック医薬品適合性評価サービス市場：用途別、2018年-2023年、2024年-2029年 世界のジェネリック医薬品適合性評価サービス市場：用途別市場シェア、2022年 ・行政&規制機関、製薬会社、学術センター、CRO、その他 世界のジェネリック医薬品適合性評価サービス市場：地域・国別、2018年-2023年、2024年-2029年 世界のジェネリック医薬品適合性評価サービス市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるジェネリック医薬品適合性評価サービスのグローバル売上、2018年-2023年 ・主要企業におけるジェネリック医薬品適合性評価サービスのグローバル売上シェア、2022年 ・主要企業におけるジェネリック医薬品適合性評価サービスのグローバル販売量、2018年-2023年 ・主要企業におけるジェネリック医薬品適合性評価サービスのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 PHDS Healthcare Research、 YUANBO、 HiCrystal、 Agilent、 Waters、 Thermo Fisher Scientific、 BOC Sciences、 JOINN、 SHIMADZU、 Tigermed、 MEDICILON、 FUKANGREN、 Shenzhen Real-chemstandards Bio-Tech.,Co.,Ltd、 Xiamen Bioendo Technology Co.,Ltd、 ChoiPharm、 WuXi AppTec、 Puhui Pharma、 Beijing Honghui Meditech Co., Ltd.、 NKD PHARM CO, LTD ************************************************************* ・調査・分析レポートの概要 ジェネリック医薬品適合性評価サービス市場の定義 市場セグメント 世界のジェネリック医薬品適合性評価サービス市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のジェネリック医薬品適合性評価サービス市場規模 世界のジェネリック医薬品適合性評価サービス市場規模：2022年 VS 2029年 世界のジェネリック医薬品適合性評価サービス市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのジェネリック医薬品適合性評価サービスの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のジェネリック医薬品適合性評価サービス製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：オンラインサービス、オフラインサービス ジェネリック医薬品適合性評価サービスのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：行政&規制機関、製薬会社、学術センター、CRO、その他 ジェネリック医薬品適合性評価サービスの用途別グローバル売上・予測 ・地域別市場分析 地域別ジェネリック医薬品適合性評価サービス市場規模 2022年と2029年 地域別ジェネリック医薬品適合性評価サービス売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） PHDS Healthcare Research、 YUANBO、 HiCrystal、 Agilent、 Waters、 Thermo Fisher Scientific、 BOC Sciences、 JOINN、 SHIMADZU、 Tigermed、 MEDICILON、 FUKANGREN、 Shenzhen Real-chemstandards Bio-Tech.,Co.,Ltd、 Xiamen Bioendo Technology Co.,Ltd、 ChoiPharm、 WuXi AppTec、 Puhui Pharma、 Beijing Honghui Meditech Co., Ltd.、 NKD PHARM CO, LTD ... |
This research report provides a comprehensive analysis of the Generic Drug Consistency Evaluation Service market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Generic Drug Consistency Evaluation Service market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Generic Drug Consistency Evaluation Service, challenges faced by the industry, and potential opportunities for market players.
The global Generic Drug Consistency Evaluation Service market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Generic Drug Consistency Evaluation Service market presents opportunities for various stakeholders, including Government & Regulatory Agencies, Pharmaceutical Company. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Generic Drug Consistency Evaluation Service market. Additionally, the growing consumer demand present avenues for market expansion.
The global Generic Drug Consistency Evaluation Service market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Generic Drug Consistency Evaluation Service market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Generic Drug Consistency Evaluation Service market.
Market Overview: The report provides a comprehensive overview of the Generic Drug Consistency Evaluation Service market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., On-line Services, Off-line Services), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Generic Drug Consistency Evaluation Service market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Generic Drug Consistency Evaluation Service market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Generic Drug Consistency Evaluation Service market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Generic Drug Consistency Evaluation Service market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Generic Drug Consistency Evaluation Service market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Generic Drug Consistency Evaluation Service market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Generic Drug Consistency Evaluation Service, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Generic Drug Consistency Evaluation Service market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Generic Drug Consistency Evaluation Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
On-line Services
Off-line Services
Market segment by Application
Government & Regulatory Agencies
Pharmaceutical Company
Academic Centre
CRO
Others
Global Generic Drug Consistency Evaluation Service Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
PHDS Healthcare Research
YUANBO
HiCrystal
Agilent
Waters
Thermo Fisher Scientific
BOC Sciences
JOINN
SHIMADZU
Tigermed
MEDICILON
FUKANGREN
Shenzhen Real-chemstandards Bio-Tech.,Co.,Ltd
Xiamen Bioendo Technology Co.,Ltd
ChoiPharm
WuXi AppTec
Puhui Pharma
Beijing Honghui Meditech Co., Ltd.
NKD PHARM CO, LTD
Outline of Major Chapters:
Chapter 1: Introduces the definition of Generic Drug Consistency Evaluation Service, market overview.
Chapter 2: Global Generic Drug Consistency Evaluation Service market size in revenue.
Chapter 3: Detailed analysis of Generic Drug Consistency Evaluation Service company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Generic Drug Consistency Evaluation Service in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Generic Drug Consistency Evaluation Service Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Generic Drug Consistency Evaluation Service Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Generic Drug Consistency Evaluation Service Overall Market Size
2.1 Global Generic Drug Consistency Evaluation Service Market Size: 2022 VS 2029
2.2 Global Generic Drug Consistency Evaluation Service Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Generic Drug Consistency Evaluation Service Players in Global Market
3.2 Top Global Generic Drug Consistency Evaluation Service Companies Ranked by Revenue
3.3 Global Generic Drug Consistency Evaluation Service Revenue by Companies
3.4 Top 3 and Top 5 Generic Drug Consistency Evaluation Service Companies in Global Market, by Revenue in 2022
3.5 Global Companies Generic Drug Consistency Evaluation Service Product Type
3.6 Tier 1, Tier 2 and Tier 3 Generic Drug Consistency Evaluation Service Players in Global Market
3.6.1 List of Global Tier 1 Generic Drug Consistency Evaluation Service Companies
3.6.2 List of Global Tier 2 and Tier 3 Generic Drug Consistency Evaluation Service Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Generic Drug Consistency Evaluation Service Market Size Markets, 2022 & 2029
4.1.2 On-line Services
4.1.3 Off-line Services
4.2 By Type – Global Generic Drug Consistency Evaluation Service Revenue & Forecasts
4.2.1 By Type – Global Generic Drug Consistency Evaluation Service Revenue, 2018-2023
4.2.2 By Type – Global Generic Drug Consistency Evaluation Service Revenue, 2024-2029
4.2.3 By Type – Global Generic Drug Consistency Evaluation Service Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Generic Drug Consistency Evaluation Service Market Size, 2022 & 2029
5.1.2 Government & Regulatory Agencies
5.1.3 Pharmaceutical Company
5.1.4 Academic Centre
5.1.5 CRO
5.1.6 Others
5.2 By Application – Global Generic Drug Consistency Evaluation Service Revenue & Forecasts
5.2.1 By Application – Global Generic Drug Consistency Evaluation Service Revenue, 2018-2023
5.2.2 By Application – Global Generic Drug Consistency Evaluation Service Revenue, 2024-2029
5.2.3 By Application – Global Generic Drug Consistency Evaluation Service Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Generic Drug Consistency Evaluation Service Market Size, 2022 & 2029
6.2 By Region – Global Generic Drug Consistency Evaluation Service Revenue & Forecasts
6.2.1 By Region – Global Generic Drug Consistency Evaluation Service Revenue, 2018-2023
6.2.2 By Region – Global Generic Drug Consistency Evaluation Service Revenue, 2024-2029
6.2.3 By Region – Global Generic Drug Consistency Evaluation Service Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Generic Drug Consistency Evaluation Service Revenue, 2018-2029
6.3.2 US Generic Drug Consistency Evaluation Service Market Size, 2018-2029
6.3.3 Canada Generic Drug Consistency Evaluation Service Market Size, 2018-2029
6.3.4 Mexico Generic Drug Consistency Evaluation Service Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Generic Drug Consistency Evaluation Service Revenue, 2018-2029
6.4.2 Germany Generic Drug Consistency Evaluation Service Market Size, 2018-2029
6.4.3 France Generic Drug Consistency Evaluation Service Market Size, 2018-2029
6.4.4 U.K. Generic Drug Consistency Evaluation Service Market Size, 2018-2029
6.4.5 Italy Generic Drug Consistency Evaluation Service Market Size, 2018-2029
6.4.6 Russia Generic Drug Consistency Evaluation Service Market Size, 2018-2029
6.4.7 Nordic Countries Generic Drug Consistency Evaluation Service Market Size, 2018-2029
6.4.8 Benelux Generic Drug Consistency Evaluation Service Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Generic Drug Consistency Evaluation Service Revenue, 2018-2029
6.5.2 China Generic Drug Consistency Evaluation Service Market Size, 2018-2029
6.5.3 Japan Generic Drug Consistency Evaluation Service Market Size, 2018-2029
6.5.4 South Korea Generic Drug Consistency Evaluation Service Market Size, 2018-2029
6.5.5 Southeast Asia Generic Drug Consistency Evaluation Service Market Size, 2018-2029
6.5.6 India Generic Drug Consistency Evaluation Service Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Generic Drug Consistency Evaluation Service Revenue, 2018-2029
6.6.2 Brazil Generic Drug Consistency Evaluation Service Market Size, 2018-2029
6.6.3 Argentina Generic Drug Consistency Evaluation Service Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Generic Drug Consistency Evaluation Service Revenue, 2018-2029
6.7.2 Turkey Generic Drug Consistency Evaluation Service Market Size, 2018-2029
6.7.3 Israel Generic Drug Consistency Evaluation Service Market Size, 2018-2029
6.7.4 Saudi Arabia Generic Drug Consistency Evaluation Service Market Size, 2018-2029
6.7.5 UAE Generic Drug Consistency Evaluation Service Market Size, 2018-2029
7 Generic Drug Consistency Evaluation Service Companies Profiles
7.1 PHDS Healthcare Research
7.1.1 PHDS Healthcare Research Company Summary
7.1.2 PHDS Healthcare Research Business Overview
7.1.3 PHDS Healthcare Research Generic Drug Consistency Evaluation Service Major Product Offerings
7.1.4 PHDS Healthcare Research Generic Drug Consistency Evaluation Service Revenue in Global Market (2018-2023)
7.1.5 PHDS Healthcare Research Key News & Latest Developments
7.2 YUANBO
7.2.1 YUANBO Company Summary
7.2.2 YUANBO Business Overview
7.2.3 YUANBO Generic Drug Consistency Evaluation Service Major Product Offerings
7.2.4 YUANBO Generic Drug Consistency Evaluation Service Revenue in Global Market (2018-2023)
7.2.5 YUANBO Key News & Latest Developments
7.3 HiCrystal
7.3.1 HiCrystal Company Summary
7.3.2 HiCrystal Business Overview
7.3.3 HiCrystal Generic Drug Consistency Evaluation Service Major Product Offerings
7.3.4 HiCrystal Generic Drug Consistency Evaluation Service Revenue in Global Market (2018-2023)
7.3.5 HiCrystal Key News & Latest Developments
7.4 Agilent
7.4.1 Agilent Company Summary
7.4.2 Agilent Business Overview
7.4.3 Agilent Generic Drug Consistency Evaluation Service Major Product Offerings
7.4.4 Agilent Generic Drug Consistency Evaluation Service Revenue in Global Market (2018-2023)
7.4.5 Agilent Key News & Latest Developments
7.5 Waters
7.5.1 Waters Company Summary
7.5.2 Waters Business Overview
7.5.3 Waters Generic Drug Consistency Evaluation Service Major Product Offerings
7.5.4 Waters Generic Drug Consistency Evaluation Service Revenue in Global Market (2018-2023)
7.5.5 Waters Key News & Latest Developments
7.6 Thermo Fisher Scientific
7.6.1 Thermo Fisher Scientific Company Summary
7.6.2 Thermo Fisher Scientific Business Overview
7.6.3 Thermo Fisher Scientific Generic Drug Consistency Evaluation Service Major Product Offerings
7.6.4 Thermo Fisher Scientific Generic Drug Consistency Evaluation Service Revenue in Global Market (2018-2023)
7.6.5 Thermo Fisher Scientific Key News & Latest Developments
7.7 BOC Sciences
7.7.1 BOC Sciences Company Summary
7.7.2 BOC Sciences Business Overview
7.7.3 BOC Sciences Generic Drug Consistency Evaluation Service Major Product Offerings
7.7.4 BOC Sciences Generic Drug Consistency Evaluation Service Revenue in Global Market (2018-2023)
7.7.5 BOC Sciences Key News & Latest Developments
7.8 JOINN
7.8.1 JOINN Company Summary
7.8.2 JOINN Business Overview
7.8.3 JOINN Generic Drug Consistency Evaluation Service Major Product Offerings
7.8.4 JOINN Generic Drug Consistency Evaluation Service Revenue in Global Market (2018-2023)
7.8.5 JOINN Key News & Latest Developments
7.9 SHIMADZU
7.9.1 SHIMADZU Company Summary
7.9.2 SHIMADZU Business Overview
7.9.3 SHIMADZU Generic Drug Consistency Evaluation Service Major Product Offerings
7.9.4 SHIMADZU Generic Drug Consistency Evaluation Service Revenue in Global Market (2018-2023)
7.9.5 SHIMADZU Key News & Latest Developments
7.10 Tigermed
7.10.1 Tigermed Company Summary
7.10.2 Tigermed Business Overview
7.10.3 Tigermed Generic Drug Consistency Evaluation Service Major Product Offerings
7.10.4 Tigermed Generic Drug Consistency Evaluation Service Revenue in Global Market (2018-2023)
7.10.5 Tigermed Key News & Latest Developments
7.11 MEDICILON
7.11.1 MEDICILON Company Summary
7.11.2 MEDICILON Business Overview
7.11.3 MEDICILON Generic Drug Consistency Evaluation Service Major Product Offerings
7.11.4 MEDICILON Generic Drug Consistency Evaluation Service Revenue in Global Market (2018-2023)
7.11.5 MEDICILON Key News & Latest Developments
7.12 FUKANGREN
7.12.1 FUKANGREN Company Summary
7.12.2 FUKANGREN Business Overview
7.12.3 FUKANGREN Generic Drug Consistency Evaluation Service Major Product Offerings
7.12.4 FUKANGREN Generic Drug Consistency Evaluation Service Revenue in Global Market (2018-2023)
7.12.5 FUKANGREN Key News & Latest Developments
7.13 Shenzhen Real-chemstandards Bio-Tech.,Co.,Ltd
7.13.1 Shenzhen Real-chemstandards Bio-Tech.,Co.,Ltd Company Summary
7.13.2 Shenzhen Real-chemstandards Bio-Tech.,Co.,Ltd Business Overview
7.13.3 Shenzhen Real-chemstandards Bio-Tech.,Co.,Ltd Generic Drug Consistency Evaluation Service Major Product Offerings
7.13.4 Shenzhen Real-chemstandards Bio-Tech.,Co.,Ltd Generic Drug Consistency Evaluation Service Revenue in Global Market (2018-2023)
7.13.5 Shenzhen Real-chemstandards Bio-Tech.,Co.,Ltd Key News & Latest Developments
7.14 Xiamen Bioendo Technology Co.,Ltd
7.14.1 Xiamen Bioendo Technology Co.,Ltd Company Summary
7.14.2 Xiamen Bioendo Technology Co.,Ltd Business Overview
7.14.3 Xiamen Bioendo Technology Co.,Ltd Generic Drug Consistency Evaluation Service Major Product Offerings
7.14.4 Xiamen Bioendo Technology Co.,Ltd Generic Drug Consistency Evaluation Service Revenue in Global Market (2018-2023)
7.14.5 Xiamen Bioendo Technology Co.,Ltd Key News & Latest Developments
7.15 ChoiPharm
7.15.1 ChoiPharm Company Summary
7.15.2 ChoiPharm Business Overview
7.15.3 ChoiPharm Generic Drug Consistency Evaluation Service Major Product Offerings
7.15.4 ChoiPharm Generic Drug Consistency Evaluation Service Revenue in Global Market (2018-2023)
7.15.5 ChoiPharm Key News & Latest Developments
7.16 WuXi AppTec
7.16.1 WuXi AppTec Company Summary
7.16.2 WuXi AppTec Business Overview
7.16.3 WuXi AppTec Generic Drug Consistency Evaluation Service Major Product Offerings
7.16.4 WuXi AppTec Generic Drug Consistency Evaluation Service Revenue in Global Market (2018-2023)
7.16.5 WuXi AppTec Key News & Latest Developments
7.17 Puhui Pharma
7.17.1 Puhui Pharma Company Summary
7.17.2 Puhui Pharma Business Overview
7.17.3 Puhui Pharma Generic Drug Consistency Evaluation Service Major Product Offerings
7.17.4 Puhui Pharma Generic Drug Consistency Evaluation Service Revenue in Global Market (2018-2023)
7.17.5 Puhui Pharma Key News & Latest Developments
7.18 Beijing Honghui Meditech Co., Ltd.
7.18.1 Beijing Honghui Meditech Co., Ltd. Company Summary
7.18.2 Beijing Honghui Meditech Co., Ltd. Business Overview
7.18.3 Beijing Honghui Meditech Co., Ltd. Generic Drug Consistency Evaluation Service Major Product Offerings
7.18.4 Beijing Honghui Meditech Co., Ltd. Generic Drug Consistency Evaluation Service Revenue in Global Market (2018-2023)
7.18.5 Beijing Honghui Meditech Co., Ltd. Key News & Latest Developments
7.19 NKD PHARM CO, LTD
7.19.1 NKD PHARM CO, LTD Company Summary
7.19.2 NKD PHARM CO, LTD Business Overview
7.19.3 NKD PHARM CO, LTD Generic Drug Consistency Evaluation Service Major Product Offerings
7.19.4 NKD PHARM CO, LTD Generic Drug Consistency Evaluation Service Revenue in Global Market (2018-2023)
7.19.5 NKD PHARM CO, LTD Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
